scholarly journals Herpetic Keratitis and Corneal Endothelitis Following COVID-19 Vaccination: A Case Series

Cureus ◽  
2022 ◽  
Author(s):  
Hassan Alkwikbi ◽  
Mohammed Alenazi ◽  
Wafi Alanazi ◽  
Shahad Alruwaili
Keyword(s):  
Case Series ◽  
Herpetic Keratitis

Herpetic keratitis and keratouveitis after mitomycin-C use in glaucoma filtering surgery: a short case series

2009 ◽  
Vol 19 (6) ◽  
pp. 1088-1090 ◽  
Author(s):  
Aparna Rao ◽  
Radihika Tandon ◽  
Namrata Sharma ◽  
Ramanjit Sihota ◽  
Viney Gupta ◽  
...  
Keyword(s):  
Mitomycin C ◽  
Case Series ◽  
Herpetic Keratitis ◽  
Filtering Surgery

scholarly journals Clinico-microbiological profile of Burkholderia cepacia keratitis: a case series

2021 ◽  
Vol 20 (1) ◽  
Author(s):  
Ming-Chih Ho ◽  
Eugene Yu-Chuan Kang ◽  
Lung-Kun Yeh ◽  
David H. K. Ma ◽  
Hsin-Chiung Lin ◽  
...  
Keyword(s):  
Burkholderia Cepacia ◽  
Case Series ◽  
Opportunistic Pathogen ◽  
Drug Susceptibility ◽  
Ocular Disease ◽  
Herpetic Keratitis ◽  
Chang Gung Memorial Hospital ◽  
Predisposing Factor ◽  
Medical Treatments ◽  
Visual Outcomes

Abstract Background Burkholderia cepacia, an opportunistic pathogen mainly affecting patients with cystic fibrosis or immunocompromised, has rarely been documented as a cause of corneal infection. The clinical and microbiological profiles of B. cepacia keratitis are reported herein. Methods We retrospectively reviewed the medical record of 17 patients with culture-proven B. cepacia keratitis, treated between 2000 and 2019 at Chang Gung Memorial Hospital, Taiwan. Our data included predisposing factors, clinical presentations, treatments, and visual outcomes of B. cepacia keratitis as well as the drug susceptibility of the causative agent. Results The most common predisposing factor for B. cepacia keratitis was preexisting ocular disease (seven, 41.2%), particularly herpetic keratitis (five). Polymicrobial infection was detected in seven (41.2%) eyes. All B. cepacia isolates were susceptible to ceftazidime. Main medical treatments included levofloxacin or ceftazidime. Surgical treatment was required in five (29.4%) patients. Only four (23.5%) patients exhibited final visual acuity better than 20/200. Conclusions B. cepacia keratitis primarily affects patients with preexisting ocular disease, particularly herpetic keratitis, and responds well to ceftazidime or fluoroquinolones. However, the visual outcomes are generally poor.

scholarly journals Clinico-microbiological Profile of Burkholderia cepacia Keratitis: a Case Series

2020 ◽  
Author(s):  
Ming-Chih Ho ◽  
Eugene Yu-Chuan Kang ◽  
Lung-Kun Yeh ◽  
David HK Ma ◽  
Hsin-Chiung Lin ◽  
...  
Keyword(s):  
Burkholderia Cepacia ◽  
Case Series ◽  
Opportunistic Pathogen ◽  
Drug Susceptibility ◽  
Ocular Disease ◽  
Herpetic Keratitis ◽  
Chang Gung Memorial Hospital ◽  
Predisposing Factor ◽  
Medical Treatments ◽  
Visual Outcomes

Abstract Background: Burkholderia cepacia, an opportunistic pathogen mainly affecting patients with cystic fibrosis or immunocompromised, has rarely been documented as a cause of corneal infection. The clinical and microbiological profiles of B. cepacia keratitis are reported herein.Methods: We retrospectively reviewed the medical record of 17 patients with culture-proven B. cepacia keratitis, treated between 2000 and 2019 at Chang Gung Memorial Hospital, Taiwan. Our data included predisposing factors, clinical presentations, treatments, and visual outcomes of B. cepacia keratitis as well as the drug susceptibility of the causative agent.Results: The most common predisposing factor for B. cepacia keratitis was preexisting ocular disease (seven, 41.2 %), particularly herpetic keratitis (5). Polymicrobial infection was detected in seven (41.2 %) eyes. All B. cepacia isolates were susceptible to ceftazidime. Main medical treatments included levofloxacin or ceftazidime. Surgical treatment was required in five (29.4 %) patients. Only four (23.5 %) patients exhibited final visual acuity better than 20/200.Conclusions: B. cepacia keratitis primarily affects patients with preexisting ocular disease, particularly herpetic keratitis, and responds well to ceftazidime or fluoroquinolones. However, the visual outcomes are generally poor.

scholarly journals Clinico-microbiological Profile of Burkholderia cepacia Keratitis: a Case Series

2020 ◽  
Author(s):  
Ming-Chih Ho ◽  
Eugene Yu-Chuan Kang ◽  
Lung-Kun Yeh ◽  
David HK Ma ◽  
Hsin-Chiung Lin ◽  
...  
Keyword(s):  
Burkholderia Cepacia ◽  
Case Series ◽  
Drug Susceptibility ◽  
Ocular Disease ◽  
Herpetic Keratitis ◽  
Chang Gung Memorial Hospital ◽  
Predisposing Factor ◽  
Medical Treatments ◽  
Visual Outcomes ◽  
Clinical Presentations

Abstract Background Burkholderia cepacia, a pathogen, has rarely been documented as a cause of corneal infection. The clinical and microbiological profiles of B. cepacia keratitis are reported herein. Methods We retrospectively reviewed the medical record of 17 patients with culture-proven B. cepacia keratitis, treated between 2000 and 2019 at Chang Gung Memorial Hospital, Taiwan. Our data included predisposing factors, clinical presentations, treatments, and visual outcomes of B. cepacia keratitis as well as the drug susceptibility of the causative agent. Results The most common predisposing factor for B. cepacia keratitis was preexisting ocular disease (7, 41.2%), particularly herpetic keratitis (5). Polymicrobial infection was detected in 7 (41.2%) eyes. All B. cepacia isolates were susceptible to ceftazidime. Main medical treatments included levofloxacin or ceftazidime. Surgical treatment was required in 5 (29.4%) patients. Only 4 (23.5%) patients exhibited final visual acuity better than 20/200. Conclusions B. cepacia keratitis primarily affects patients with preexisting ocular disease, particularly herpetic keratitis, and responds well to ceftazidime or fluoroquinolones. However, the visual outcomes are generally poor.

Abstract #856 A Case Series Review of Clinical and Biochemical Characteristics of Pituitary Abcess in Mexican Patients

2018 ◽  
Vol 24 ◽  
pp. 202-203
Author(s):  
Mireya Perez-Guzman ◽  
Alfredo Nava de la Vega ◽  
Arturo Pena Velarde ◽  
Tania Raisha Torres Victoria ◽  
Froylan Martinez-Sanchez ◽  
...  
Keyword(s):  
Case Series ◽  
Biochemical Characteristics ◽  
Mexican Patients

Cannabis-associated arteritis

VASA ◽  
2010 ◽  
Vol 39 (1) ◽  
pp. 43-53 ◽  
Author(s):  
Grotenhermen
Keyword(s):  
Systematic Review ◽  
Case Reports ◽  
Case Series ◽  
Cardiovascular Effects ◽  
Causative Factor ◽  
Cannabis Use ◽  
Thromboangiitis Obliterans ◽  
Pathological Features ◽  
Scientific Support ◽  
Clinical And Pathological Features

Background: To investigate the hypothesis that cases of arteritis similar to thromboangiitis obliterans (TAO) and associated with the use of cannabis were caused by cannabis or THC (dronabinol), or that cannabis use is a co-factor of TAO. Patients and methods: A systematic review on case reports and the literature on so-called cannabis arteritis, TAO, and cardiovascular effects of cannabinoids was conducted. Results: Fifteen reports with 57 cases of an arteritis associated with the use of cannabis and two additional case series of TAO, in which some patients also used cannabis, were identified. Clinical and pathological features of cannabis-associated arteritis do not differ from TAO and the major risk factor of TAO, tobacco use, was present in most, if not in all of these cases. The proposed pathophysiological mechanisms for the development of an arteritis by cannabis use are not substantiated. Conclusions: The hypothesis of cannabis being a causative factor or co-factor of TAO or an arteritis similar to TAO is not supported by the available evidence. The use of the term “cannabis arteritis” should be avoided until or unless more convincing scientific support is forthcoming.

Sign in / Sign up

Export Citation Format

Share Document